2011—2015年我国制药产业空间集聚发展趋势分析  

Analysis of Trends on Spatial Agglomeration of Pharmaceutical Industry of China from 2011 to 2015

作　　者：陈昕[1] 张亚[1] 龚时薇[1] CHEN Xin;ZHANG Ya;GONG Shiwei(Department of Pharmacy Business and Administration,School of Pharmacy,Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430030,China)

机构地区：[1]华中科技大学同济医学院药学院医药商贸系,武汉430030

出　　处：《医药导报》2017年第12期1442-1447,共6页Herald of Medicine

基　　金：国家自然科学基金面上项目(71373089)

摘　　要：促进我国制药产业的空间集聚水平,是提高国家产业竞争力的重要措施。运用空间基尼系数、区域产业集中度和集聚指数对2011—2015年10月我国制药产业空间集聚状况及速度进行测算和分析。目前我国的三大制药产业已形成空间集聚,主要集聚在东部地区,尤其是山东、江苏和广东省。其中,化学制药主要集中在山东、江苏、广东和北京;中成药产业则集中在山东、四川、吉林和江西;生物制药集中在山东、江苏、河南。从发展速度上看,生物制药和中成药呈现集聚加速,而化学制药出现集聚萎缩;化学制药、中成药和生物制药产业集聚速度增长最快的省份分别为吉林、西藏和江西;西部地区的生物制药产业集聚增长明显。建议发挥地方政府主导作用,制定企业集群发展的配套政策,建立产学研药品创新激励机制,优化产业组合,实现集聚效应与持续的区域竞争优势。Improving the spatial agglomeration level of regional pharmaceutical industry is an important measure to promote the competitive ability of national industry.We used three evaluation indicators,Spatial Gini Coefficient,Location Concentration Ratio and Agglomeration Index,was to calculate the degree and speed of regional agglomeration of pharmaceutical industry from2011to Oct2015.At present,China's pharmaceutical industry has formed spatial concentration,particularly concentrates in Shandong,Jiangsu and Guangdong.And the chemical pharmaceutical industry mainly concentrates in Shandong,Jiangsu,Guangdong and Beijing;Chinese traditional medicine industry concentrates in Shandong,Sichuan,Jilin and Jiangxi;biopharmaceutical industry concentrates in Shandong,Jiangsu,Henan.From the point of view of development speed,the agglomeration speeds of bio pharmaceutical and traditional medicine industry are accelerating compared with the shrink of chemical pharmaceutical industry.Three provinces of the greatest growing speed of agglomeration for chemical,traditional medicine and bio pharmaceutical industry are Jilin,Tibet and Jiangxi,respectively.Agglomeration growth of biopharmaceutical industry in western region is prominent.This paper suggests that the national government should play a leading role in the development of regional cluster for pharmaceutical industry.Some effective measures should be taken which include formulating the supporting policies of enterprise cluster,establishing the incentive system of drug innovation and optimizing the industrial portfolio in order to promote the formation of regional sustainable competitive advantage through agglomeration effect.

关 键 词：制药产业 空间聚集 集聚速度 竞争力 

分 类 号：R951[医药卫生—药学] R956